2015
DOI: 10.1089/thy.2015.0277
|View full text |Cite|
|
Sign up to set email alerts
|

Development and Pilot Testing of an Encounter Tool for Shared Decision Making About the Treatment of Graves' Disease

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
29
0

Year Published

2016
2016
2024
2024

Publication Types

Select...
5
3

Relationship

2
6

Authors

Journals

citations
Cited by 47 publications
(29 citation statements)
references
References 20 publications
0
29
0
Order By: Relevance
“…[17][18][19][20][21][22][23] Recordings were audiovisual or audio-only based on the preferences of the patients and their clinicians at the time of enrollment. Of the 272 complete videos available for analyses from these trials, we included all the videos that were recorded in specialty care (51) and selected a random sample of 61 videos from the 221 remaining primary care videos stratified by treatment arm (decision aid use) to complete a sample of 112 videos.…”
Section: Methodsmentioning
confidence: 99%
“…[17][18][19][20][21][22][23] Recordings were audiovisual or audio-only based on the preferences of the patients and their clinicians at the time of enrollment. Of the 272 complete videos available for analyses from these trials, we included all the videos that were recorded in specialty care (51) and selected a random sample of 61 videos from the 221 remaining primary care videos stratified by treatment arm (decision aid use) to complete a sample of 112 videos.…”
Section: Methodsmentioning
confidence: 99%
“…Ablative therapies include radioactive iodine treatment (RAI) or the surgical removal of the thyroid tissue. All available treatment options are effective and relatively safe and the initial therapeutic strategy for a newly diagnosed patient with GH remains a choice that the patient and the treating physician could take together after discussing each of the treatment options, including among others the drawbacks and the potential side effects (36,37).…”
Section: Prediction Of the Risk Of Recurrence After Antithyroid Drugsmentioning
confidence: 99%
“…The choice depends on objective medical criteria (risk of recurrence, indications and contraindications for each option) and on the patient's preference: i.e., expectations and fears. The pros and cons of each option should therefore be explained [1][2][3][4][5][6] ( Table 1).…”
mentioning
confidence: 99%
“…Choice of treatment strategy is a major element of management. As none of the 3 options shows clear superiority [3], the feasibility, advantages and drawbacks of each should be discussed in detail with the patient and family [5]. Where there are no specific contraindications, the patient's fears and expectations can be taken fully into account.…”
mentioning
confidence: 99%
See 1 more Smart Citation